Multysensory disorders in neurodegenerative diseases related to aging

Igor V. Litvinenko , Konstantin M. Naumov

Russian Military Medical Academy Reports ›› 2022, Vol. 41 ›› Issue (4) : 415 -420.

PDF
Russian Military Medical Academy Reports ›› 2022, Vol. 41 ›› Issue (4) : 415 -420. DOI: 10.17816/rmmar111855
Reviews
review-article

Multysensory disorders in neurodegenerative diseases related to aging

Author information +
History +
PDF

Abstract

Disorders of the sensory systems (vision, hearing, etc.) in the elderly are often considered as a natural process of body changes over time (presbyopia, age-related hearing loss, presbiataxia, etc.) and remain untreated. However, nowadays reliable data show the connection of sensory system disorders with the onset of cognitive impairment. On the other hand there is the evidence that complaints about the functioning of individual sensory systems may be the first symptoms of the developing neurodegenerative disease ahead of its manifestation by several years. This suggests that early detection and development of measures for compensation and treatment of processes and diseases that cause disturbances in the work of sensory systems will both improve the quality of early diagnosis of neurodegenerative diseases and delay the clinical manifestation of neurodegenerative diseases. The data show the necessity of an integrated approach to diagnosis in patients with complaints of visual, hearing, balance and walking disorders in order to develop the set of measures for the correction and treatment of the identified disorders and diseases.

Keywords

Alzheimer’s disease / cognitive disorders / hearing impairment / neurodegenerative diseases / Parkinson’s disease / sensory systems / standing and walking disorders / visual impairment

Cite this article

Download citation ▾
Igor V. Litvinenko, Konstantin M. Naumov. Multysensory disorders in neurodegenerative diseases related to aging. Russian Military Medical Academy Reports, 2022, 41(4): 415-420 DOI:10.17816/rmmar111855

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Naumov KM, Dynin PS, Simarev AN, et al. The role of visual perception disorders in the development of cognitive disorders. Bulletin of the Russian Military Medical Academy. 2020;(S3):140. (In Russ.)

[2]

Наумов К.М., Дынин П.С., Симарев А.Н., и др. Роль нарушений зрительного восприятия в развитии когнитивных расстройств // Вестник Российской Военно-медицинской академии. 2020. № S3. С. 140.

[3]

Dynin PS, Naumov KM, Litvinenko IV, Alizade MR. Identification of visual and spatial disorders in Parkinson’s disease. In: Neural Networks and Neurotechnologies. Saint Petersburg: ВВМ Publishing House; 2019. P. 221–225.

[4]

Dynin P.S., Naumov K.M., Litvinenko I.V., Alizade M.R. Identification of visual and spatial disorders in Parkinson’s disease. In: Neural Networks and Neurotechnologies. Санкт-Петербург: Издательство ВВМ; 2019. P. 221–225.

[5]

Zarkali A, McColgan P, Leyland LA, et al. Visual Dysfunction Predicts Cognitive Impairment and White Matter Degeneration in Parkinson’s Disease. Mov Disord. 2021;36(5):1191–1202. DOI: 10.1002/mds.28477

[6]

Zarkali A., McColgan P., Leyland L.A., et al. Visual Dysfunction Predicts Cognitive Impairment and White Matter Degeneration in Parkinson’s Disease // Mov. Disord. 2021. Vol. 36, No. 5. P. 1191–1202. DOI: 10.1002/mds.28477

[7]

Mancino R, Martucci A, Cesareo M, et al. Glaucoma and Alzheimer Disease: One Age-Related Neurodegenerative Disease of the Brain. Curr Neuropharmacol. 2018;16(7):971–977. DOI: 10.2174/1570159X16666171206144045

[8]

Mancino R., Martucci A., Cesareo M., et al. Glaucoma and Alzheimer Disease: One Age-Related Neurodegenerative Disease of the Brain // Curr. Neuropharmacol. 2018. Vol. 16, No. 7. P. 971–977. DOI: 10.2174/1570159X16666171206144045

[9]

Shenal BV, Jackson MD, Crucian GP, et al. Finger agnosia in Alzheimer disease. Cogn Behav Neurol. 2006;19(4):202–203. DOI: 10.1097/01.wnn.0000213921.02891.1b

[10]

Shenal B.V., Jackson M.D., Crucian G.P., et al. Finger agnosia in Alzheimer disease // Cogn. Behav. Neurol. 2006. Vol. 19, No. 4. P. 202–203. DOI: 10.1097/01.wnn.0000213921.02891.1b

[11]

Vanegas-Arroyave N, Chen DF, Lauro PM, et al. Where Do Parkinson’s Disease Patients Look While Walking? Mov Disord. 2022;37(4):864–869. DOI: 10.1002/mds.28917

[12]

Vanegas-Arroyave N., Chen D.F., Lauro P.M., et al. Where Do Parkinson’s Disease Patients Look While Walking? // Mov. Disord. 2022. Vol. 37, No. 4. P. 864–869. DOI: 10.1002/mds.28917

[13]

Liu Z, Yang Z, Gu Y, et al. The effectiveness of eye tracking in the diagnosis of cognitive disorders: A systematic review and meta-analysis. PLoS One. 2021;16(7): e0254059. DOI: 10.1371/journal.pone.0254059

[14]

Liu Z., Yang Z., Gu Y.,. et al. The effectiveness of eye tracking in the diagnosis of cognitive disorders: A systematic review and meta-analysis // PLoS One. 2021. Vol. 16, No. 7. Art. E0254059. DOI: 10.1371/journal.pone.0254059

[15]

Jung J, Bae SH, Han JH, et al. Relationship between Hearing Loss and Dementia Differs According to the Underlying Mechanism. J Clin Neurol. 2021;17(2):290–299. DOI: 10.3988/jcn.2021.17.2.290

[16]

Jung J., Bae S.H., Han J.H., et al. Relationship between Hearing Loss and Dementia Differs According to the Underlying Mechanism // J. Clin. Neurol. 2021. Vol. 17, No. 2. P. 290–299. DOI: 10.3988/jcn.2021.17.2.290

[17]

Loughrey DG, Kelly ME, Kelley GA, et al. Association of Age-Related Hearing Loss with Cognitive Function, Cognitive Impairment, and Dementia: A Systematic Review and Meta-analysis. JAMA Otolaryngol Head Neck Surg. 2018;144(2):115–126. DOI: 10.1001/jamaoto.2017.2513

[18]

Loughrey D.G., Kelly M.E., Kelley G.A., et al. Association of Age-Related Hearing Loss with Cognitive Function, Cognitive Impairment, and Dementia: A Systematic Review and Meta-analysis // JAMA Otolaryngol. Head Neck Surg. 2018. Vol. 144, No. 2. P. 115–126. DOI: 10.1001/jamaoto.2017.2513

[19]

Johnson JCS, Marshall CR, Weil RS. Hearing and dementia: from ears to brain. Brain. 2021;144(2):391–401. DOI: 10.1093/brain/awaa429

[20]

Johnson J.C.S., Marshall C.R., Weil R.S. Hearing and dementia: from ears to brain. // Brain. 2021. Vol. 144, No. 2. P. 391–401. DOI: 10.1093/brain/awaa429

[21]

Mulrow CD, Aguilar C, Endicott JE, et al. Association between hearing impairment and the quality of life of elderly individuals. J Am Geriatr Soc. 1990;38(1):45–50. DOI: 10.1111/j.1532-5415.1990.tb01595.x

[22]

Mulrow C.D., Aguilar C., Endicott J.E., et al. Association between hearing impairment and the quality of life of elderly individuals // J. Am. Geriatr. Soc. 1990. Vol. 38, No. 1. P. 45–50. DOI: 10.1111/j.1532-5415.1990.tb01595.x

[23]

Cohen JA, Verghese J. Gait and dementia. Handb Clin Neurol. 2019;167:419–427. DOI: 10.1016/b978-0-12-804766-8.00022-4

[24]

Cohen J.A., Verghese J. Gait and dementia // Handb. Clin. Neurol. 2019. Vol. 167. P. 419–427. DOI: 10.1016/b978-0-12-804766-8.00022-4

[25]

Beauchet O, Launay CP, Fantino B, Annweiler C, Allali G. Episodic memory and executive function impairments in non-demented older adults: which are the respective and combined effects on gait performances? Age (Dordr). 2015;37(4):9812. DOI: 10.1007/s11357-015-9812-y

[26]

Beauchet O., Launay C.P., Fantino B., Annweiler C., Allali G. Episodic memory and executive function impairments in non-demented older adults: which are the respective and combined effects on gait performances? // Age (Dordr). 2015. Vol. 37, No. 4. Art. 9812. DOI: 10.1007/s11357-015-9812-y

[27]

Morley JE. Gait, Falls, and Dementia. J Am Med Dir Assoc. 2016;17(6):467–470. DOI: 10.1016/j.jamda.2016.03.024

[28]

Morley J.E. Gait, Falls, and Dementia // J. Am. Med. Dir. Assoc. 2016. Vol. 17, No. 6. P. 467–470. DOI: 10.1016/j.jamda.2016.03.024

[29]

Litvinenko IV, Krasakov IV, Bisaga GN, et al. Modern conception of the pathogenesis of neurodegenerative diseases and therapeutic strategy. The Korsakov’s Journal of Neurology and Psychiatry. 2017;117(6 Pt 2):3–10. (In Russ.) DOI: 10.17116/jnevro2017117623-10

[30]

Литвиненко И.В., Красаков И.В., Бисага Г.Н., и др. Современная концепция патогенеза нейродегенеративных заболеваний и стратегия терапии // Журнал неврологии и психиатрии им. C.C. Корсакова. 2017. Т. 117, № 6–2. С. 3–10. DOI: 10.17116/jnevro2017117623-10

[31]

Litvinenko IV, Оdinak М.М., Khlystov YuV, et al. Efficacy and safety of rivastigmine (exelon) in the confusion syndrome in the acute phase of ischemic stroke. The Korsakov’s Journal of Neurology and Psychiatry. 2010;110(11 Pt 2):36–41. (In Russ.)

[32]

Литвиненко И.В., Одинак М.М., Хлыстов Ю.В., и др. Эффективность и безопасность ривастигмина (экселона) при синдроме спутанности сознания в остром периоде ишемического инсульта // Журнал неврологии и психиатрии им. C.C. Корсакова. 2010. Т. 110, № 11–2. С. 36–41.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

156

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/